InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375
$5.50 -3.00% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.50 −77.04% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 29 Oct 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Operating income−26.7Net income−26.5EPS, diluted−24.00Fiscal year 2021Operating income−51.1Net income−51.2EPS, diluted−8.16Fiscal year 2022Operating income−97.2Net income−94.6EPS, diluted−3.02Fiscal year 2023Revenue129.0Operating income−3.2Net income−6.7EPS, diluted−0.20Fiscal year 2024Revenue210.8 +63.4%Operating income47.0Net income65.6EPS, diluted1.68Fiscal year 2025Revenue25.4 −87.9%Operating income−157.9Net income−143.8 −319.0%EPS, diluted−3.47
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 129.0 210.8 25.4
Growth +63.4% −87.9%
Operating income −26.7 −51.1 −97.2 −3.2 47.0 −157.9
Net income −26.5 −51.2 −94.6 −6.7 65.6 −143.8
Growth −319.0%
EPS, diluted −24.00 −8.16 −3.02 −0.20 1.68 −3.47

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−2.5%Net margin−5.2%Free cash flow margin104.0%Fiscal year 2024Operating margin22.3%Net margin31.1%Free cash flow margin−21.2%Fiscal year 2025Operating margin−621.1%Net margin−565.5%Free cash flow margin−509.6%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a −2.5% 22.3% −621.1%
Net margin n/a n/a n/a −5.2% 31.1% −565.5%
Free cash flow margin n/a n/a n/a 104.0% −21.2% −509.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−25.6Capital expenditure−2.3Free cash flow−27.9Fiscal year 2021Operating cash flow−50.9Capital expenditure−4.6Free cash flow−55.4Fiscal year 2022Operating cash flow−93.8Capital expenditure−2.9Free cash flow−96.7Fiscal year 2023Operating cash flow139.8Capital expenditure−5.6Free cash flow134.2Fiscal year 2024Operating cash flow−41.6Capital expenditure−3.2Free cash flow−44.7 −133.3%Fiscal year 2025Operating cash flow−128.5Capital expenditure−1.0Free cash flow−129.6
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −25.6 −50.9 −93.8 139.8 −41.6 −128.5
Capital expenditure −2.3 −4.6 −2.9 −5.6 −3.2 −1.0
Free cash flow −27.9 −55.4 −96.7 134.2 −44.7 −129.6
Growth −133.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash39.0Shareholders’ equity−41.5Fiscal year 2021Cash291.1Shareholders’ equity298.7Fiscal year 2022Cash45.2Shareholders’ equity212.6Fiscal year 2023Cash67.6Shareholders’ equity242.4Fiscal year 2024Cash101.2Shareholders’ equity428.7Fiscal year 2025Cash90.4Shareholders’ equity306.1
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 39.0 291.1 45.2 67.6 101.2 90.4
Shareholders’ equity −41.5 298.7 212.6 242.4 428.7 306.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a −2.5% 22.3% −621.1%
n/a n/a n/a −5.2% 31.1% −565.5%
n/a n/a n/a 104.0% −21.2% −509.6%
Spending
n/a n/a n/a 77.4% 59.4% 559.7%
n/a n/a n/a 25.0% 18.2% 161.5%
n/a n/a n/a 4.4% 1.5% 4.1%
Returns
n/a −17.1% −44.5% −2.8% 15.3% −47.0%
−60.9% −16.7% −37.5% −1.4% 12.5% −38.1%
Balance and payout
7.7% 2.3% 15.7% 48.3% 18.6% 18.9%